Superworth20/20 Biolabs shares outstanding AIDX
Diluted shares outstanding, averaged over each quarter, from 2025.
- Latest quarter, to Jun 30, 2026
- 10.8M
- On a year earlier
- +123.7%
- more shares
20/20 Biolabs had 10.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 123.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 10.8M | +124% | |
| Q1 FY26 | 7.7M | +59% | |
| Q2 FY25 | 4.8M | n/a | |
| Q1 FY25 | 4.8M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on 20/20 Biolabs
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.